GRB7 and breast cancer: CircCDYL2 could stabilize GRB7 via inhibiting its ubiquitination degradation and strengthen the interaction between GRB7 and FAK, thus sustaining the activities of AKT and ERK1/2 and further promoting trastuzumab resistance in BC [90].